SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-035947
Filing Date
2023-11-01
Accepted
2023-11-01 16:02:57
Documents
68
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gthx-20230930.htm   iXBRL 10-Q 1047844
2 EX-10.1 gthx-2023x0930xex101.htm EX-10.1 18063
3 EX-31.1 gthx-20230930xex311.htm EX-31.1 10851
4 EX-31.2 gthx-20230930xex312.htm EX-31.2 10916
5 EX-32.1 gthx-20230930xex321.htm EX-32.1 5627
6 EX-32.2 gthx-20230930xex322.htm EX-32.2 5691
12 gthx-20230930_g1.jpg GRAPHIC 8623
  Complete submission text file 0001628280-23-035947.txt   5851949

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gthx-20230930.xsd EX-101.SCH 45866
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gthx-20230930_cal.xml EX-101.CAL 49204
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gthx-20230930_def.xml EX-101.DEF 216746
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gthx-20230930_lab.xml EX-101.LAB 555193
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gthx-20230930_pre.xml EX-101.PRE 366113
62 EXTRACTED XBRL INSTANCE DOCUMENT gthx-20230930_htm.xml XML 714305
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 231368118
SIC: 2834 Pharmaceutical Preparations